Dicerna Pharmaceuticals is a startup based in the United States, 1 tracked investor.
Dicerna Pharmaceuticals is a company headquartered in the United States. Brouky records 1 investor associated with the company.
Dicerna Pharmaceuticals develops RNA interference (RNAi) therapeutics to treat rare and prevalent diseases by silencing disease-causing genes.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.